Abstract
In the last decade there has been significant controversy about the appropriateness, efficacy, safety, and wisdom of treating chronic pain patients (CPPs) with opioids. Arguments against their use have included concerns about tolerance, dependence, addiction, persistent side effects, and interference with physical or psychosocial functioning. However, considerable experience and research with long-term cancer pain treatment suggests that in appropriately selected patients, opioids have a low morbidity, and a low addiction potential, and in addition to the primary analgesic action, can facilitate reduction in suffering, enhance functional activity level, and improve quality of life without significant risk of addictive behaviors. Some patients, however, are at risk. Risk factors for addiction are discussed in this article.
Similar content being viewed by others
References and Recommended Reading
Snyder CA: An open letter to physicians who have patients with chronic nonmalignant pain. J Law Med Ethics 1994, 22:204–205.
Katz J, Kavanagh BP, Sandler AN, et al.: Pre-emptive analgesia: clinical evidence of neuroplasticity contributing to postoperative pain. Anesthesiology 1992, 77:439–446.
Richmond CE, Bromley LM, Woolf CJ: Preoperative morphine preempts postoperative pain. Lancet 1993, 342:73–75.
Collins R, Brandner B, Bromley LM, Woolf CJ: Is there any clinical advantage of increasing the preemptive dose of morphine or combining pre-incisional with postoperative morphine administration? Br J Anaesth 1995, 74:396–399.
Zech DFJ, Grong S, Lynch J, et al.: Validation of the World Health Organization guidelines for cancer pain relief: a 10 year prospective study. Pain 1996, 63:65–76.
Patt RB, Burton AW: Pain associated with advanced malignancy, including adjuvant analgesic drugs in cancer pain management. In Evaluation & Treatment of Chronic Pain, edn 3. Edited by Aronoff GM. Baltimore: Williams & Wilkins; 1999:337–376.
Portenoy RK: Opioid therapy for chronic nonmalignant pain: a review of the critical issues. Special section on opioids for nonmalignant pain. Part 1. J Pain Symptom Manage 1996, 11:203–217. Detailed discussion on the use of opioids with high-risk patients. Reviews clinical issues as well as barriers to adequate pain care.
Von Roenn JH, Cleeland CS, Gonin R, et al.: Physicians attitudes and practice in cancer pain management. Ann Intern Med 1993, 119:121–126.
Cleeland CS, Gonin R, Hatfield AK, et al.: Pain and its treatment in out-patients with metastatic cancer. N Engl J Med 1994, 330:592–596.
Ferrell BR, Cohen MZ, Rhiner M, Rozek A: Pain as a metaphor for illness. Part 1: family caregivers’ management of pain. Oncol Nurs Forum 1991, 18:1315–1321.
McCaffery M, Ferrell BR: Correcting misconceptions about pain assessment and use of opioid analgesics: educational strategies aimed at public concerns. Nurs Outlook 1996, 44:184–190.
Jacox A, Carr DB, Payne R, et al.: Management of Cancer Pain: Adults Quick Reference Guide. No. 9. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services; 1994. AHCPR publication no. 94-0593.
Acute Pain Management Guideline Panel: In Acute Pain Management in Adults: Operative Procedures. Quick Reference Guide for Clinicians. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services; 1992. AHCPR publication no 92-0019.
Haddox JD, Joranson D, Angarola RT, et al.: The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997, 13:6–8.
Joranson DE, Cleeland CS, Weissman DE, Gilson AM: Opioids for chronic cancer and non-cancer pain: a survey of state medical board members. Fed Bull 1992, 4:15–49.
Arkinstall W, Sandler A, Babel N, et al.: Efficacy of controlledrelease codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain 1995, 62:169–178.
Moulin DE, Iezzi A, Amireh R, et al.: Randomized trial of oral morphine for chronic non-cancer pain. Lancet 1996, 347:143–147.
Portenoy RK: Opioid therapy in nonmalignant pain. J Pain Symptom Manage 1990, 5:S46-S62.
Taub A: Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin. In Narcotic Analgesics in Anesthesiology. Edited by Kitahata LM, Collins D. Baltimore: Williams & Wilkins; 1982:199–208.
Brookoff D, Palomano R: Treating sickle cell pain like cancer pain. Ann Intern Med 1992, 116:364–368.
France RD, Urban BJ, Keefe FJ: Long-term use of narcotic analgesics in chronic pain. Soc Sci Med 1984, 19:1379–1382.
Green J, Coyle M: Methadone use in the control of nonmalignant chronic pain. Pain Manage 1989, Sept/Oct:241–246.
Kell MJ, Musselman DL: Methadone prophylaxis of intractable headache pain control and serum opioid levels. AJPM 1993, 3:7–14.
Portenoy RK, Foley KM: Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986, 25:171–186.
Tennant FS, Uelman GF: Narcotic maintenance for chronic pain: medical and legal guidelines. Postgrad Med 1983, 73:81–94.
Tennant FS, Robinson D, Sagherian A, Seecof R: Chronic opioid treatment of intractable non-malignant pain. Pain Manage 1988, Jan/Feb:18–36.
Urban BJ, France RD, Steinberger DL, et al.: Long-term use of narcotic antidepressant medication in the management of phantom limb pain. Pain 1986, 24:191–197.
Zenz M, Strumpf M, Tryba M: Long-term opioid therapy in patients with chronic non-malignant pain. J Pain Symptom Manage 1992, 7:69–77.
Buckley FP, Sizemore WA, Charlton JE: Medication management in patients with chronic nonmalignant pain: a review of the use of a drug withdrawal protocol. Pain 1986, 26:153–166.
Finlayson RD, Maruta T, Morse BR: Substance dependence and chronic pain: profile of 50 patients treated in an alcohol and drug dependence unit. Pain 1986, 26:167–174.
Finlayson RD, Maruta T, Morse BR, Martin MA: Substance dependence and chronic pain: experience with treatment and follow-up results. Pain 1986, 26:175–180.
Maruta T: Prescription drug-induced organic brain syndrome. Am J Psychiatry 1978, 135:376–377.
Maruta T, Swanson DW: Problems with the use of oxycodone compounds in patients with chronic pain. Pain 1981, 11:389–396.
Maruta T, Swanson DW, Finlayson RE: Drug abuse and dependency in patients with chronic pain. Mayo Clinic Proc 1979, 54:241–244.
McNairy SL, Maruta T, Ivnak RJ, et al.: Prescription medication dependence and neuropsychologic function. Pain 1984, 18:169–177.
Ready LB, Sarkis E, Turner JA: Self-reported vs. actual use of medications in chronic pain patients. Pain 1982, 12:285–294.
Turner JA, Calsyn DA, Fordyce WE, Ready LB: Drug utilization pattern in chronic pain patients. Pain 1982, 12:357–363.
Aronoff GM, Wagner JM, Spangler AS Jr: Chemical interventions for pain. J Consult Clin Psychol 1986, 54:769–775.
World Health Organization: Cancer Pain Relief. Geneva: WHO; 1986.
Weissman DE, Haddox JD: Opioid pseudoaddiction— an iatrogenic syndrome. Pain 1989, 36:363–366.
Aronoff GM: Evaluation and Treatment of Chronic Pain, edn 3. Edited by Aronoff GM. Baltimore: Williams & Wilkins; 1999: 433–453.
Jaffe J: Opiates: clinical aspects. In Substance Abuse: A Comprehensive Textbook, edn 2. Edited by Lowinson J et al. Baltimore: Williams and Wilkins; 1992:186–194.
Portenoy RK, Payne R: Acute and chronic pain. In Substance Abuse: A Comprehensive Textbook, edn 2. Edited by Lowinson JH et al. Baltimore: Williams and Wilkins; 1992:691–721.
Twycross RG, Lack SA: Symptom Control in Far Advanced Cancer: Pain Relief. London: Pitman Books; 1983.
Foley KM: The treatment of cancer pain. N Engl J Med 1985, 313:84–95.
Twycross RG: Clinical experience with diamorphine in advanced malignant disease. Int J Clin Pharmacol Ther Toxicol 1974, 9:184–198.
Kanner RM, Foley KM: Patterns of narcotic drug use in a cancer pain clinic. Ann N Y Acad Sci 1981, 362:161–172.
Gourlay GK, Cherry DA, Cousins MJ: A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 1986, 25:297–312.
Portenoy RK, Foley KM, Inturrisi CE: The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 1990, 43:273–286.
Aronoff GM: Pain centers: treatment for intractable suffering and disability resulting from chronic pain. In Evaluation and Treatment of Chronic Pain, edn 3. Edited by Aronoff GM. Baltimore: Williams and Wilkins; 1999:591–603.
Zacny JP: Opioids and chronic pain. Letter to the editor. Clin J Pain 1998, 14:89–91.
Zacny JP: A review of the effects of opioids on psychomotor and cognitive functioning in humans. Exp Clin Psychopharmacol 1995, 3:432–466.
Starmer GA: A review of the effects of analgesics on driving performance. In Drugs and Driving. Edited by O’Hanlon JF, deGier JJ. London: Taylor & Francis; 1986:251–269.
Chesher GB: Understanding the opioid analgesics and their effects on skills performance. Alcohol Drugs Driving 1989, 5:111–138.
Hanks GW, O’Neill WM, Simpson P, et al.: The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. Eur J Clin Pharmacol 1995, 48:455–460.
Vainio A, Ollila J, Matikainen E, et al.: Driving ability in cancer patients receiving long-term morphine analgesia. Lancet 1995, 346:667–670.
Hanks GW: Morphine sans morpheus. Lancet 1995, 346:652–653.
Smith AM: Patients taking stable doses of morphine may drive [letter]. Br Med J 1996, 312:56–57.
Kappes S, Laux G: Driving performance of opiate addicts under methadone supported rehabilitation. Pharmacopsychiatry 1995, 28:191.
Lodemann E, Leifer K, Kluwig J, et al.: Methadone maintenance and driving ability. Pharmacopsychiatry 1995, 28:199.
O’Neill WM, Hanks GW, McIntyre E, et al.: An investigation of the cognitive effects of repeated doses of opioid analgesics in volunteers. Eur J Clin Invest 1995, 25:379.
Shannon CN, Baranowski: Use of opioids in non-cancer pain. Brit J Hosp Med 1997, 58:9:459–462.
Savage SR: Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage 1996, 11:274–286.
Hoffman NG, Olofsson O, Salen B, Wickstrom L: Prevalence of abuse and dependency in chronic pain patients. Int J Addict 1995, 30:919–927.
Miotto K, Compton P, Ling W, Conolly M: Diagnosing addictive disease in chronic pain patients. Psychosomatics 1996, 37:223–235.
Aronoff GM: Psychodynamics and psychotherapy of the chronic pain patient. In Evaluation and Treatment of Chronic Pain, edn 3. Edited by Aronoff GM. Baltimore: Williams and Wilkins; 1999:283–290.
Aronoff GM: Psychiatric Aspects of Nonmalignant Chronic Pain: A New Nosology. In Evaluation and Treatment of Chronic Pain, edn 3. Edited by Aronoff GM. Baltimore: Williams and Wilkins; 1999:291–300.
Blumer D: Psychiatric considerations in pain. In Spine, vol 2. Edited by Rothman RH, Simeone FA. Philadelpia: Saunders; 1975.
Pilowski I, Spence ND: 69. Pilowski I, Spence ND: Psychodynamic aspects of the pain experience. In Psychology of Pain. Edited by Sternbach RA. New York: Raven Press; 1978.
Sifneos PE: The prevalence of “alexithymic” characteristics in psychosomatic patients. Psychother Psychosom 1973, 22:255–262.
Hackett TP: The chronic pain patient: evaluation and treatment in Massachusets General Hospital. In Handbook of General Hospital Psychiatry. Edited by Hackett TP, Cassem NH. St. Louis: Mosby; 1978.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 3 revised. Washington: American Psychiatric Association; 1987.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington: American Psychiatric Association; 1994.
Vourakis C: Substance abuse concerns in the treatment of pain. Nurs Clin North Am 1998, 33:47–60.
Ferrell BR, Griffith H: Cost issues related to pain management: report from the cancer pain panel of the agency for health care policy and research. J Pain Symptom Manage 1994, 9:221–234.
Ward SE, Gordon D: Application of the American Pain Society quality assurance standards. Pain 1994, 56:299–306.
Hill HE, Haertzen CA, Davis H: An MMPI factor analytic study of alcoholics, narcotic addicts and criminals. Q J Stud Alcohol 1962, 23:411–431.
Hill HE, Haertzen CA, Glaser R: Personality characteristics of narcotic addicts as indicated by the MMPI. J Gen Psychol 1960, 62:127–139.
Sawe J, Hansen J, Ginman C, et al.: A patient-controlled dose regimen of methadone in chronic cancer pain. Br Med J 1981, 282:771–773.
Engel GL: Psychogenic pain and the pain-prone patient. Am J Med 1959, 26:899–918.
Blumer D, Heilbronn M: Chronic Pain as a variant of depressive disease: the pain-prone disorder. J Nerv Ment Dis 1982, 170:381–406.
Fishman SM, Bandman TB, Edwards A, Borsook D: The opioid contract in the management of chronic pain. J Pain Symptom Manage 1999, 18:27–37.
Haddox JD, Aronoff GM: Commentary: the potential for unintended consequences from public policy shifts in the treatment of pain. J Law Med Ethics 1998, 26:350–352. Will assist physicians in understanding factors shaping newer trends in opioids regulation and prescribing practices.
California Pain Patient’s Bill of Rights, California Health & Safety Code 1.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aronoff, G.M. Opioids in chronic pain management: Is there a significant risk of addiction?. Current Review of Pain 4, 112–121 (2000). https://doi.org/10.1007/s11916-000-0044-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11916-000-0044-0